ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26265173)

Published in J Oncol Pract on August 11, 2015

Authors

Mehmet Sitki Copur1, Ryan Ramaekers2, Mithat Gönen2, Mary Gulzow2, Rebecca Hadenfeldt2, Courtney Fuller2, Jenifer Scott2, Sarah Einspahr2, Heather Benzel2, Mary Mickey2, Max Norvell2, Douglas Clark2, Dron Gauchan2, Dax Kurbegov2, Mehmet Sitki Copur1, Ryan Ramaekers2, Mithat Gönen2, Mary Gulzow2, Rebecca Hadenfeldt2, Courtney Fuller2, Jenifer Scott2, Sarah Einspahr2, Heather Benzel2, Mary Mickey2, Max Norvell2, Douglas Clark2, Dron Gauchan2, Dax Kurbegov2

Author Affiliations

1: Saint Francis Cancer Treatment Center, Grand Island, NE; Memorial Sloan Kettering Cancer Center, New York, NY; and Catholic Health Initiatives, Denver, CO mcopur@sfmc-gi.org.
2: Saint Francis Cancer Treatment Center, Grand Island, NE; Memorial Sloan Kettering Cancer Center, New York, NY; and Catholic Health Initiatives, Denver, CO.

Articles cited by this

Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81

Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA (2006) 11.22

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol (2001) 6.83

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol (2002) 4.68

Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol (2000) 3.70

Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol (2004) 3.18

Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol (2007) 2.46

Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval. J Clin Oncol (2009) 2.38

Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer (2010) 2.15

American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12

Representation of older patients in cancer treatment trials. Cancer (1994) 2.06

Factors influencing inclusion of patients with malignancies in clinical trials. Cancer (2006) 1.76

Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. J Clin Oncol (2005) 1.74

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst (1993) 1.68

The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer (2005) 1.67

Funding oncology clinical trials: are cooperative group trials sustainable? J Clin Oncol (2012) 1.56

Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program. Implement Sci (2009) 1.55

Clinical research by community oncologists. CA Cancer J Clin (2003) 1.50

Clinical trial enrollment of rural patients with cancer. Cancer Pract (2002) 1.44

Predictors of enrollment in lung cancer clinical trials. Cancer (2006) 1.26

Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program. Clin Trials (2015) 0.87

The changing face of research in community practice. J Oncol Pract (2014) 0.78